YH guided the idea and the experiments and selleck chemicals revised the manuscript. All authors have read and approved the final manuscript.”
“Background Magnetic resonance (MR) imaging is a superior molecular imaging technique for clinical diagnosis of cancer because it provides noninvasive tomographic imaging with high spatial resolution [1, 2]. The sensitivity of MR imaging has significantly improved in recent years by using magnetic nanocrystal (MNC) because

an enhanced T2 shortening effect is ascribed to the high crystallinity GDC-0068 price of MNC [3–5]. In particular, the immobilization of a targeting moiety on the magnetic nanocrystal has facilitated biomarker-specific molecular imaging by MR [6]. Thus, biomarker-specific molecular imaging for cancer enables early and specific detection of cancer cells and facilitates analysis of disease progression to improve the survival rate of cancer patients [7, 8]. Glioblastoma is the most common and lethal intracranial tumor. This brain cancer exhibits a relentless malignant progression with characteristics of widespread invasion, destruction

of normal brain tissue, resistance to conventional therapeutic approaches, and certain death. In addition, glioblastoma is among the most highly vascular of all CB-839 solid tumors. Although there are marked genomic differences between primary (de novo pathway) and secondary (progressive pathway) glioblastoma, a physiological adaptation to hypoxia and critical genetic mutations commonly converge on a final tumor angiogenesis pathway. Therefore, precise molecular imaging of glioblastoma can be a crucial step for effective treatment [9, 10]. Recent studies have identified key angiogenic factors, such as basic fibroblast growth factor, interleukin-8, hypoxia-inducible factors, and vascular endothelial over growth

factor A (VEGFA). Among these, VEGFA and one of its receptors (vascular endothelial growth factor receptor 2, VEGFR2) have been established as the primary proangiogenic factors [11, 12]. In this study, we developed a VEGFR2-targetable MR imaging probe to enable precise recognition of angiogenic vasculature of glioblastoma. To synthesize a sensitive MR imaging contrast agent, monodispersed MNC (Fe3O4) with high crystallinity was synthesized by thermal decomposition method and subsequently enveloped with tri-armed carboxyl polysorbate 80 by a nanoemulsion method. To prepare the magnetic nanoprobe for specific binding with VEGFR2 on angiogenic vessels, VEGFR2-specific aptamers (Apt) based on nucleic acid were immobilized on the surface of carboxylated MNC. Recently, Apt based on single-stranded nucleic acid molecules have been developed as a targeting moiety due to their high affinity and selectivity for a variety of chemical and biological molecules [13].